Sh. Hari Chem.

Who are the top shareholders of the Sh. Hari Chem.?

The top shareholders of Sh. Hari Chem. include Om Pareek Investment Company Limited with 10.47% and Din Bhandu Jalan as the largest public shareholder at 1.38%. Individual investors hold a total of 35.91%, with no mutual funds or foreign institutional investors involved, and no pledged promoter holdings.

The top shareholders of Sh. Hari Chem. include Om Pareek Investment Company Limited, which holds the highest promoter stake at 10.47%. In terms of public shareholders, Din Bhandu Jalan is the largest, with a holding of 1.38%. Additionally, individual investors collectively hold 35.91% of the company's shares. There are no mutual funds or foreign institutional investors currently holding shares in the company, and there are no pledged promoter holdings.

how big is Sh. Hari Chem.?

As of Jun 06, Shree Hari Chemicals Export Ltd has a market capitalization of 61.36 Cr, classifying it as a Micro Cap company, with recent net sales of 141.20 Cr and a net profit of 5.10 Cr over the last four quarters.

Market Cap: As of Jun 06, Shree Hari Chemicals Export Ltd has a market capitalization of 61.36 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters, which includes data from Mar'25, Dec'24, Sep'24, and Jun'24, is 141.20 Cr. The sum of Net Profit for the same period is 5.10 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is Standalone data for the reporting period of Mar'24. The Shareholder's Funds are valued at 20.29 Cr, and the Total Assets amount to 62.82 Cr.

Who are in the management team of Sh. Hari Chem.?

As of March 2022, the management team of Sh. Hari Chem. includes Bankesh Chandra Agrawal (Chairman & Managing Director), Sanjay Kedia (Whole Time Director & CFO), and several independent directors, among others. The team is responsible for the company's governance and operational management.

As of March 2022, the management team of Sh. Hari Chem. includes the following individuals:<BR><BR>1. Bankesh Chandra Agrawal - Chairman & Managing Director<BR>2. Virjanand Gupta - Independent Director<BR>3. Ekta Sultania - Independent Director<BR>4. Urvashi Pandya - Company Secretary & Compliance Officer<BR>5. Sanjay Kedia - Whole Time Director & CFO<BR>6. Sarthak Agarwal - Whole-time Director<BR>7. Nihit Agarwal - Whole-time Director<BR>8. Parag Agrawal - Independent Director<BR>9. Shri Ram Ramrichhapal Gupta - Independent Director<BR><BR>These individuals hold various positions within the company, contributing to its governance and operational management.

What does Sh. Hari Chem. do?

Shree Hari Chemicals Export Ltd manufactures dye intermediates and operates in the commodity chemicals industry as a micro-cap company. As of March 2025, it reported net sales of 35 Cr and a market cap of Rs 61 Cr.

Overview:<BR>Shree Hari Chemicals Export Ltd is engaged in the manufacture of dye intermediates and operates within the commodity chemicals industry, classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in 1987 as a Private Limited Company and was converted into a Public Limited Company in 1993. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 35 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap: Rs 61 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 12.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.98 <BR>Return on Equity: 22.51% <BR>Price to Book: 2.74 <BR><BR>Contact Details:<BR>Address: A/8 M I D C Indl Area, Mahad Raigad Maharashtra : 402309 <BR>Tel: 91-2145-232177/233492 <BR>Email: info@shreeharichemicals.in <BR>Website: http://www.shreeharichemicals.com

Has Sh. Hari Chem. declared dividend?

Shree Hari Chemicals Export Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of August 24, 2017. However, the dividend yield is 0%, as it did not contribute to returns in recent periods, despite significant price returns over the long term.

Shree Hari Chemicals Export Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1<BR>- Ex-date: 24 Aug 17<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6 months period, the price return was -2.27%, the dividend return was 0%, resulting in a total return of -2.27%.<BR><BR>For the 1 year period, the price return was 97.67%, the dividend return was 0%, leading to a total return of 97.67%.<BR><BR>Over the 2 years period, the price return was 216.63%, with a dividend return of 0%, culminating in a total return of 216.63%.<BR><BR>In the 3 years period, the price return was 136.0%, the dividend return was 0%, which resulted in a total return of 136.0%.<BR><BR>During the 4 years period, the price return was 79.08%, with a dividend return of 0%, giving a total return of 79.08%.<BR><BR>For the 5 years period, the price return was 599.75%, the dividend return was 0%, resulting in a total return of 599.75%.<BR><BR>Overall, while Shree Hari Chemicals Export Ltd declared a dividend, the dividend yield remains at 0%, indicating that the dividend did not contribute to returns in the recent periods. However, the company has shown significant price returns over various periods, particularly in the long term.

Who are the peers of the Sh. Hari Chem.?

Sh. Hari Chem.'s peers include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Gayatri BioOrga., Genus Prime, Camex, and Haryana Leather. In terms of management risk, Sh. Hari Chem. has a below-average rating, while its 1-year return stands at 107.03%, significantly higher than Camex's -19.98%.

Peers: The peers of Sh. Hari Chem. are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Gayatri BioOrga., Genus Prime, Camex, and Haryana Leather.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar. Average management risk is noted for Tata Chemicals, India Glycols, and Haryana Leather, while Below Average management risk is seen at Fischer Medical and Sh. Hari Chem. Gayatri BioOrga. and Genus Prime do not qualify for management risk assessment. Growth is classified as Good for Sh. Hari Chem. and Below Average for Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, and Camex, while Fischer Medical has Average growth. Gayatri BioOrga. and Genus Prime do not qualify for growth assessment. Capital Structure is Excellent for GHCL, Good for Fischer Medical, Average for Tata Chemicals, India Glycols, Sh. Hari Chem., and Camex, while Chemplast Sanmar has Below Average capital structure, and Haryana Leather has Good capital structure.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.85%, while Camex has the lowest at -19.98%. Sh. Hari Chem.'s 1-year return of 107.03% is significantly higher than Camex's. Additionally, Camex and Haryana Leather have negative six-month returns.

What is the technical trend for Sh. Hari Chem.?

As of May 30, 2025, Sh. Hari Chem. shows a mildly bullish trend overall, but mixed signals from weekly indicators, including a mildly bearish MACD and Bollinger Bands, temper this outlook.

As of 30 May 2025, the technical trend for Sh. Hari Chem. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, indicating mixed signals across time frames. The weekly Bollinger Bands are bearish, contrasting with the monthly Bollinger Bands which are mildly bullish. Daily moving averages are mildly bullish, suggesting some short-term support. The KST shows a mildly bearish stance on the weekly chart but is bullish on the monthly, further contributing to the mixed outlook. Dow Theory indicates a mildly bearish trend in both weekly and monthly assessments. Overall, the current stance is mildly bullish, but the strength is tempered by bearish signals in the weekly indicators.

Is Sh. Hari Chem. overvalued or undervalued?

As of June 20, 2025, Sh. Hari Chem. is considered very attractive and undervalued with a PE ratio of 11.88, significantly lower than its peers, and strong fundamentals indicated by a ROCE of 18.76% and ROE of 22.51%, despite recent stock performance lagging behind the Sensex.

As of 20 June 2025, the valuation grade for Sh. Hari Chem. has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued, with a PE ratio of 11.88, an EV to EBITDA ratio of 7.84, and a PEG ratio of 0.01, all of which suggest strong fundamentals relative to its price. <BR><BR>In comparison to its peers, Sh. Hari Chem.'s PE ratio is notably lower than that of Solar Industries at 126.83 and Godrej Industries at 46.43, highlighting its relative value in the commodity chemicals sector. Additionally, the company's ROCE stands at 18.76% and ROE at 22.51%, further emphasizing its efficient use of capital. Despite recent stock performance lagging behind the Sensex over the past month and year-to-date, the long-term returns of 490.93% over five years suggest a strong growth potential that supports the undervaluation narrative.

When is the next results date for Sh. Hari Chem.?

The next results date for Sh. Hari Chem. is 13 August 2025.

The next results date for Sh. Hari Chem. is scheduled for 13 August 2025.

How has been the historical performance of Sh. Hari Chem.?

Sh. Hari Chem. showed positive financial growth from March 2024 to March 2025, with net sales increasing to 141.20 Cr and profit after tax rising to 5.10 Cr. However, the company experienced a net cash outflow of 3.00 Cr in March 2025, reversing the previous year's inflow.

Answer:<BR>The historical performance of Sh. Hari Chem. shows a positive trend in key financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Sh. Hari Chem. reported net sales of 141.20 Cr, an increase from 138.33 Cr in the previous year. Total operating income also rose to 141.20 Cr from 138.33 Cr, despite a rise in raw material costs from 73.41 Cr to 82.83 Cr. The total expenditure, excluding depreciation, decreased to 130.61 Cr from 134.52 Cr, leading to an operating profit (PBDIT) of 11.46 Cr, up from 8.17 Cr. Profit before tax improved significantly to 6.93 Cr from 3.22 Cr, resulting in a profit after tax of 5.10 Cr, compared to 2.29 Cr the prior year. The earnings per share (EPS) increased to 10.34 from 5.15, reflecting a stronger profitability margin, with the PAT margin rising to 3.61% from 1.66%. On the balance sheet, total assets grew to 79.60 Cr from 62.82 Cr, while total liabilities increased to 79.60 Cr from 62.82 Cr. The company experienced a net cash outflow of 3.00 Cr in March 2025, contrasting with a net inflow of 3.00 Cr in March 2024, indicating a shift in cash flow dynamics.

Are Shree Hari Chemicals Export Ltd latest results good or bad?

Shree Hari Chemicals Export Ltd's latest results show a significant annual profit increase of 5,100% and a 17.67% revenue growth, but quarterly performance declined with a 14.75% drop in profit and a severe contraction in operating margins to 1.12%. Investors should be cautious due to reliance on non-operating income and operational challenges.

Shree Hari Chemicals Export Ltd's latest results present a mixed picture. On one hand, the company reported a significant year-on-year increase in net profit for Q4 FY26, surging by 5,100% to ₹1.04 crore, and revenue also grew by 17.67% to ₹41.22 crore compared to the same quarter last year. However, these figures are somewhat misleading due to the heavy reliance on non-operating income, which accounted for a substantial portion of the profit.<BR><BR>On the downside, the company experienced a decline in both net profit and revenue compared to the previous quarter, with net profit down 14.75% and revenue down 7.35%. More concerning is the severe contraction in operating margins, which fell to just 1.12% from 3.03% a year earlier, indicating challenges in maintaining profitability amid rising costs.<BR><BR>Overall, while the annual growth figures may seem promising, the quarterly performance suggests operational difficulties and volatility in earnings, raising questions about the sustainability of this growth. Investors should be cautious given the company's reliance on non-core income and the significant margin compression.

Should I buy, sell or hold Shree Hari Chemicals Export Ltd?

Why is Shree Hari Chemicals Export Ltd falling/rising?

As of 02-Jun, Shree Hari Chemicals Export Ltd's stock price is at 104.15, down 0.81%. The stock has significantly underperformed, declining 20.50% year-to-date and 27.24% over the past year, while also trading below its moving averages and experiencing reduced investor interest.

As of 02-Jun, Shree Hari Chemicals Export Ltd's stock price is currently at 104.15, reflecting a decrease of 0.85, or 0.81%. The stock has been on a downward trend, having underperformed its sector by 1.84% today and experiencing consecutive falls over the last two days, resulting in a total decline of 8.57% during this period. <BR><BR>In terms of broader performance, the stock has shown a significant decline year-to-date, down 20.50%, and has fallen 27.24% over the past year, while the benchmark Sensex has only decreased by 12.40% and 8.26%, respectively. This indicates that Shree Hari Chemicals is not only underperforming compared to the market but also struggling significantly in its own right.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which is typically a bearish signal. There has also been a notable drop in investor participation, with delivery volume decreasing by 30.37% compared to the 5-day average, suggesting reduced interest from investors.<BR><BR>Overall, the combination of poor recent performance, declining investor participation, and trading below moving averages contributes to the stock's falling price.

Which are the latest news on Sh. Hari Chem.?